An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
Description
The capacity of SARS-CoV-2 to evolve poses challenges to conventional prevention and treatment options such as vaccination and monoclonal antibodies, as they rely on viral receptor binding domain (RBD) sequences from previous strains. Additionally
